When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RARX - Ra Pharma finalizing design of Phase 3 zilucoplan study in myasthenia gravis; shares up 2% premarket
Ra Pharmaceuticals Inc.
Ra Pharmaceuticals (NASDAQ:RARX) is up 2% premarket on light volume on the heels of its announcement that it has completed its End-of-Phase 2 interactions with the FDA and is putting the finishing touches on a pivotal Phase 3 study evaluating zilucoplan in patients with generalized myasthenia gravis (gMG), an autoimmune disorder characterized by weakness in the skeletal muscles.
More news on: Ra Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,